You just read:

Caris Life Sciences' Molecular Intelligence Platform Measures Prevalence of Oncogenic Homologous Recombination Pathway Mutations across 53,000 Tumors

News provided by

Caris Life Sciences

Jun 05, 2017, 07:30 ET